Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002071948-26-000002
Filing Date
2026-02-27
Accepted
2026-02-27 18:08:53
Documents
1
Period of Report
2026-02-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1772233729.html 4  
1 FORM 4 wk-form4_1772233729.xml 4 3456
  Complete submission text file 0002071948-26-000002.txt   4962
Mailing Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039
Business Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039 (866) 771-8946
Caris Life Sciences, Inc. (Issuer) CIK: 0002019410 (see all company filings)

EIN.: 852077369 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address 750 W. JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039
Business Address
Fredrickson David Paul (Reporting) CIK: 0002071948 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42706 | Film No.: 26702430